Xiangjun Han
China Medical University (PRC)
12 Papers
37 Citations
Xiangjun Han is an academic researcher from China Medical University (PRC). The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 7 publications. Previous affiliations of Xiangjun Han include Oregon Health & Science University.
Chat about Author
Papers
Applications of nanoparticles in biomedical imaging.
TL;DR: Nanoparticle-based contrast agents employed in most common biomedical imaging modalities, including fluorescence imaging, MRI, CT, US, PET and SPECT are reviewed, addressing their structure related features, advantages and limitations.
466
Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO2@(DOX + ILS) drug-loaded microspheres in rabbit VX2 liver tumours.
Jingsong Mao,Shunsong Tang,Duo Hong,Fan Zhao,Meng Niu,Xiangjun Han,Ji Qi,Han Bao,Yutian Jiang,Changhui Fu,Dan Long,Xianwei Meng,Hongying Su +12 more
TL;DR: Novel mPEG-PLGA@ZrO2@(DOX + ILS) microspheres can achieve good therapeutic efficacy, in combination with MW ablation and chemotherapy, while embolizing the blood vessels of arterial tumors.
31
Transarterial Delivery of a Biodegradable Single-Agent Theranostic Nanoprobe for Liver Tumor Imaging and Combinatorial Phototherapy.
Olena Taratula,Oleh Taratula,Xiangjun Han,Younes Jahangiri,Y. Tomozawa,Masahiro Horikawa,Barry Uchida,Hassan A. Albarqi,Canan Schumann,Shay Bracha,Tetiana Korzun,Khashayar Farsad +11 more
TL;DR: Biodegradable nanoparticle delivery to liver tumors from a transarterial approach enabled selective in vivo tumor imaging and combinatorial phototherapy, and selectively accumulated within viable tumor by NIR fluorescence.
12
Tumor Thermal Ablation Enhancement by Micromaterials.
TL;DR: Benefits of microcapsules and microbubbles serving as ultrasound contrast and ablation sensibilizers, in conjunction with tumor thermal ablation are explored.
11
Elevated procalcitonin levels in primary hepatic neuroendocrine carcinoma: Case report and literature review.
TL;DR: Procalcitonin (PCT) has been identified as a tumor biomarker in medullary thyroid carcinoma and plays an indicative role as a biomarker during therapy.
6